Mobile Site ›
Print Page Email Page
Print Friendly View

Test ID: GHIV    
HIV-1 Genotypic Drug Resistance Mutation Analysis, Plasma

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Identification of key HIV genotypic mutations associated with resistance to nucleotide reverse-transcriptase inhibitors, nonnucleotide reverse-transcriptase inhibitors, and protease inhibitors

 

Guiding initiation or change of anti-HIV-1 treatment regimens

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See HIV Treatment Monitoring Algorithm in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Reverse Transcription-Polymerase Chain Reaction (RT-PCR)/DNA Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

HIV-1 Genotypic Drug Resistance, P

Aliases Lists additional common names for a test, as an aid in searching

HIV Genotyping
HIV Resistance
HIV-1 Drug Resistance Mutation Analysis
HIV-1 Genotyping for Drug Resistance
HIV-1 Mutation Analysis
AIDS (acquired immune deficiency syndrome)
Human Immunodeficiency Virus (HIV)